Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer (vol 13, 1011810, 2023)

被引：0

作者：

Peng, Yurong ^{[1
]}

Li, Zhuo ^{[2
]}

Fu, Yucheng ^{[1
]}

Pan, Yue ^{[1
]}

Zeng, Yue ^{[1
]}

Liu, Junqi ^{[1
]}

Xiao, Chaoyue ^{[1
]}

Zhang, Yingzhe ^{[1
]}

Su, Yahui ^{[3
]}

Li, Guoqing ^{[3
]}

Wu, Fang ^{[1
]}

机构：

[1] Cent South Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China

[2] Cent South Univ, Xiangya Hosp 2, Ophthalmol Ctr, Changsha, Hunan, Peoples R China

[3] Cent South Univ, XiangYa Sch Publ Hlth, Changsha, Hunan, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 13卷

关键词：

perioperative period perioperative immunotherapy; neoadjuvant therapies; immunotherapy; neoadjuvant immune monotherapy; adjuvant therapy; biomarkers; NSCLC; lung cancer;

D O I：

10.3389/fonc.2023.1163376

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 50 条

[21] Perioperative immunotherapy for resectable non-small-cell lung cancer
Xiaodong Yang
Dongliang Bian
Jie Yang
Liang Duan
Haifeng Wang
Deping Zhao
Gening Jiang
Yuming Zhu
Peng Zhang
Clinical Cancer Bulletin, 3 (1):
[22] Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives
Lim, Sun Min
Hong, Min Hee
Kim, Hye Ryun
IMMUNE NETWORK, 2020, 20 (01)
[23] Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
Soh, Junichi
Hamada, Akira
Fujino, Toshio
Mitsudomi, Tetsuya
CANCERS, 2021, 13 (16)
[24] Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer
Qiu, Bin
Cai, Kaican
Chen, Chun
Chen, Jun
Chen, Ke-Neng
Chen, Qi-Xun
Cheng, Chao
Dai, Tian-Yang
Fan, Junqiang
Fan, Zhaohui
Hu, Jian
Hu, Wei-Dong
Huang, Yun-Chao
Jiang, Ge-Ning
Jiang, Jie
Jiang, Tao
Jiao, Wen-Jie
Li, He-Cheng
Li, Qiang
Liao, Yong-De
Liu, Hong-Xu
Liu, Jun-Feng
Liu, Lunxu
Liu, Yang
Long, Hao
Luo, Qing-Quan
Ma, Hai-Tao
Mao, Nai-Quan
Pan, Xiao-Jie
Tan, Fengwei
Tan, Li-Jie
Tian, Hui
Wang, Dong
Wang, Wen-Xiang
Wei, Li
Wu, Nan
Wu, Qing-Chen
Xiang, Jiaqing
Xu, Shi-Dong
Yang, Lin
Zhang, Hao
Zhang, Lanjun
Zhang, Peng
Zhang, Yi
Zhang, Zhenfa
Zhu, Kunshou
Zhu, Yuming
Um, Sang-Won
Oh, In-Jae
Tomita, Yusuke
TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (09) : 3713 - 3736
[25] Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
Zhang, Xiaofei
Zhang, Jianguo
Liu, Peiyi
Wang, Juan
Zhao, Kuaile
Zhu, Zhengfei
Gu, Kangsheng
Zhao, Weixin
FRONTIERS IN ONCOLOGY, 2023, 13
[26] Rechallenge of immunotherapy in non-small cell lung cancer patients - navigating indications and evolving perspectives
Knetki-Wroblewska, Magdalena
Chmielewska, Izabela
Wojas-Krawczyk, Kamila
Krzakowski, Maciej
ONCOLOGY IN CLINICAL PRACTICE, 2024, 20 (06): : 428 - 437
[27] The Value of Perioperative Immunotherapy for Non-Small Cell Lung Cancer: A Pool- and Meta-Analysis
Wu, Yanmeng
Hu, Lin
Zhang, Shuling
Zhang, Hui
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
[28] Immunotherapy in the landscape of new targeted treatments for non-small cell lung cancer
Gerard, Catherine
Debruyne, Channa
MOLECULAR ONCOLOGY, 2009, 3 (5-6) : 409 - 424
[29] Biomarkers of response to immunotherapy in early stage non-small cell lung cancer
Dugage, Matthieu Roulleaux
Albarran-Artahona, Victor
Laguna, Juan Carlos
Chaput, Nathalie
Vignot, Stephane
Besse, Benjamin
Mezquita, Laura
Auclin, Edouard
EUROPEAN JOURNAL OF CANCER, 2023, 184 : 179 - 196
[30] The use of immunotherapy in older patients with advanced non-small cell lung cancer
Tagliamento, Marco
Frelaut, Maxime
Baldini, Capucine
Naigeon, Marie
Nencioni, Alessio
Chaput, Nathalie
Besse, Benjamin
CANCER TREATMENT REVIEWS, 2022, 106

← 1 2 3 4 5 →